Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. VERA
VERA logo

VERA

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

VERA News

Vera Therapeutics Grants Stock Awards to New Chief Legal Officer

3d agoNewsfilter

Vera Therapeutics Appoints New Chief Legal Officer

5d agoNewsfilter

Kynam Capital Management Cuts Viridian Stake by Over $81 Million

Mar 21 2026Yahoo Finance

Kynam Capital Reduces Stake in Cogent Biosciences by $48 Million

Mar 21 2026Yahoo Finance

Integral Health Increases Stake in Vera Therapeutics by $3.55 Million

Mar 20 2026Fool

Integral Health Increases Stake in Vera Therapeutics

Mar 20 2026NASDAQ.COM

Eversept Partners Increases Stake in Vera Therapeutics

Mar 16 2026NASDAQ.COM

Eversept Partners Increases Stake in Vera Therapeutics

Mar 16 2026Fool

Deerfield Increases Stake in Vera Therapeutics

Mar 13 2026Fool

Vertex's Experimental Drug Trial Success Boosts Shares by 9%

Mar 10 2026CNBC

Vertex's Drug Success in Phase 3 Trial Paves Way for Kidney Disease Expansion

Mar 10 2026Newsfilter

Analysis of VERA Options Trading and Risks

Mar 09 2026NASDAQ.COM

Vera Therapeutics Appoints New Board Member

Mar 05 2026Newsfilter

Vera Therapeutics Raises $261M in Public Offering at $42.50 per Share

Feb 26 2026seekingalpha

Vera Therapeutics Appoints New Chief Commercial Officer

Jan 28 2026Newsfilter

Vera Therapeutics Grants 344,750 Stock Options and RSUs to New Employees

Jan 09 2026Globenewswire